A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder.
about
Linking Mitochondria to Synapses: New Insights for Stress-Related Neuropsychiatric DisordersPharmacological approaches to the challenge of treatment-resistant depressionIncorporating Natural Products, Pharmaceutical Drugs, Self-Care and Digital/Mobile Health Technologies into Molecular-Behavioral Combination Therapies for Chronic DiseasesChronic high-dose creatine has opposing effects on depression-related gene expression and behavior in intact and sex hormone-treated gonadectomized male and female rats.Oral scopolamine augmentation for major depression.Isovaleric acid in stool correlates with human depression.Creatine, similarly to ketamine, affords antidepressant-like effects in the tail suspension test via adenosine A₁ and A2A receptor activation.Gender Differences in Depressive Symptom Profile: Results from Nationwide General Population Surveys in KoreaCreatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot StudyCreatine target engagement with brain bioenergetics: a dose-ranging phosphorus-31 magnetic resonance spectroscopy study of adolescent females with SSRI-resistant depression.Effects of creatine monohydrate supplementation and exercise on depression-like behaviors and raphe 5-HT neurons in mice.Omega-3 polyunsaturated fatty acids for major depressive disorder.Nutritional strategies for dealing with depression.A mitochondrial bioenergetic basis of depression.Curcumin as a putative antidepressant.Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.An Open-Label Pilot Study of Combined Augmentation With Creatine Monohydrate and 5-Hydroxytryptophan for Selective Serotonin Reuptake Inhibitor- or Serotonin-Norepinephrine Reuptake Inhibitor-Resistant Depression in Adult Women.Structural correlates of the creatine transporter function regulation: the undiscovered country.Creatine and creatine forms intended for sports nutrition.An astroglial basis of major depressive disorder? An overview.Pramipexole augmentation in treatment-resistant major depressive disorder.American Academy of Pain Medicine and Integrative Healthcare Symposium.The modulation of NMDA receptors and L-arginine/nitric oxide pathway is implicated in the anti-immobility effect of creatine in the tail suspension test.Creatine, Similar to Ketamine, Counteracts Depressive-Like Behavior Induced by Corticosterone via PI3K/Akt/mTOR Pathway.A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression.Creatine Prevents Corticosterone-Induced Reduction in Hippocampal Proliferation and Differentiation: Possible Implication for Its Antidepressant Effect.Increased pregenual anterior cingulate glucose and lactate concentrations in major depressive disorder.Involvement of PI3K/Akt Signaling Pathway and Its Downstream Intracellular Targets in the Antidepressant-Like Effect of Creatine.The Emerging Field of Nutritional Mental Health
P2860
Q26765236-08F1B9ED-C289-47D2-B95A-014B60547859Q26798241-409A9B3E-CDB0-4B88-8B4B-5E12E12F9C05Q28069705-C17FDA5B-9C54-4E6F-9E41-A76CD8DBEF25Q30389926-CA2280F6-E824-44DF-A563-3A41BEF951D4Q34318539-E6230276-D2A7-41AC-840F-974421E9458EQ35566808-F6767A05-3C94-43A7-A953-19CEB76E5151Q35587857-52DDF665-01CF-40C1-91AD-26CB65350586Q36241751-9B516306-43B9-423C-80DC-2D53EEE9C3F7Q36387048-2E615BB1-4F20-4231-BC40-A5C0A120C93DQ37153400-5ED6F025-58AA-49FD-B77B-1EF15BC237DAQ37345200-73E2D7A5-456B-4FFF-8C5C-4C50F6726501Q38148244-D4E1D912-8FE5-4F70-A4DD-8D67B7D52133Q38155089-9FA2DC03-7003-468F-8C19-285875690926Q38254909-F2145390-6263-41B3-92C7-F08D6F5110BCQ38341731-2BE45CAD-D3A3-42CA-8C82-2F34388339AFQ38476909-80900CD5-95C4-4259-BEF0-7DC96C0B476BQ38645491-E8EAB4C6-4882-4CBE-81D8-5A82796E5E63Q38764046-25934530-922D-4BA1-B737-2871A592B758Q39055380-8C4FD4B6-E893-4066-BDBB-901FADAE24E8Q39186841-38ED7518-F8AB-4882-ACA2-D8C11AA06E53Q39301010-54BAB0AB-FCAC-4857-B127-7DF3142C60DFQ39620870-A9DF7CAC-B661-4F14-A8FC-DBFB7E2E8DFAQ41630586-F0C40C1B-F2BB-4EA5-9D60-68A5F2C9B21DQ47616820-E5BE77B6-873B-4DB3-BCF4-C3EECF0D1AA7Q47695444-A9B1B042-D73A-4483-A57F-EDA7BBF5F489Q48039679-15E884C4-1129-4C89-831A-D2C24CB5F79BQ48055338-6027FD23-EAC6-481B-A42B-FEE3E136F325Q48083788-3348B665-712B-4581-856F-31474E98C042Q56675883-84BDA0B9-9CE6-4717-ABA7-B658C7C5EB14
P2860
A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A randomized, double-blind pla ...... ith major depressive disorder.
@ast
A randomized, double-blind pla ...... ith major depressive disorder.
@en
A randomized, double-blind pla ...... ith major depressive disorder.
@nl
type
label
A randomized, double-blind pla ...... ith major depressive disorder.
@ast
A randomized, double-blind pla ...... ith major depressive disorder.
@en
A randomized, double-blind pla ...... ith major depressive disorder.
@nl
prefLabel
A randomized, double-blind pla ...... ith major depressive disorder.
@ast
A randomized, double-blind pla ...... ith major depressive disorder.
@en
A randomized, double-blind pla ...... ith major depressive disorder.
@nl
P2093
P2860
P1476
A randomized, double-blind pla ...... ith major depressive disorder.
@en
P2093
In Kyoon Lyoo
Jaeuk Hwang
Jieun E Kim
Sujung Yoon
Tae-Suk Kim
Wangyoun Won
P2860
P304
P356
10.1176/APPI.AJP.2012.12010009
P407
P577
2012-09-01T00:00:00Z